Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases (2021)
Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: ARTERIOSCLEROSE, DIABETES MELLITUS, LIPÍDEOS, OBESIDADE, RESISTÊNCIA À INSULINA
ABNT
GUIMARAES, Raphael C. e GONÇALVES, Tiago T. e LEIRIA, Luiz Osório Silveira. Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases. British Journal of Pharmacology, v. 178, n. 3, p. 531-549, 2021Tradução . . Disponível em: https://doi.org/10.1111/bph.15321. Acesso em: 04 set. 2024.APA
Guimaraes, R. C., Gonçalves, T. T., & Leiria, L. O. S. (2021). Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases. British Journal of Pharmacology, 178( 3), 531-549. doi:10.1111/bph.15321NLM
Guimaraes RC, Gonçalves TT, Leiria LOS. Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases [Internet]. British Journal of Pharmacology. 2021 ; 178( 3): 531-549.[citado 2024 set. 04 ] Available from: https://doi.org/10.1111/bph.15321Vancouver
Guimaraes RC, Gonçalves TT, Leiria LOS. Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases [Internet]. British Journal of Pharmacology. 2021 ; 178( 3): 531-549.[citado 2024 set. 04 ] Available from: https://doi.org/10.1111/bph.15321